SAN FRANCISCO —The glucagon-like peptide-1 (GLP-1) agonist liraglutide (Victoza, Novo Nordisk) taken every day preserved postprandial insulin secretion for 1 year after type 1 diabetes diagnosis in ...
The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of ...
HealthDay on MSN
Pill shows promise for treatment of type 1 diabetes
A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, ...
The REBOOT trial enrolled more than 8,400 patients recovering from a heart attack whose heart function was above 40% and assigned them to either take a beta blocker or no beta blocker within two weeks ...
Beta cell function following a hyperglycemic load properly compensated insulin sensitivity lost with kidney dysfunction in older men, preserving the net balance between the two, according to research ...
Please provide your email address to receive an email when new articles are posted on . Greater weight loss at 1 year with tirzepatide improved the odds for sustaining an HbA1c of 6.5% or less at 2 ...
The .NET library (formerly called .NET Core) doesn't have built-in functions for classical statistics analyses. But it is possible to implement such functions from scratch. This article presents C# ...
The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of ...
Recent research results from the TGF-beta and cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL) provide a better understanding of the role of the TGF-beta cytokine in ...
Low-Dose Antithymocyte Globulin Effective in Preserving Beta-Cell Function in Type 1 Diabetes: Study
Belgium: A phase 2 international trial published in The Lancet has found that low-dose antithymocyte globulin (ATG) can slow ...
News-Medical.Net on MSN
Verapamil shows potential for preserving beta-cell function in type 1 diabetes
New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results